Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Case Comprehensive Cancer Center
This multicentered study will enroll participants into two cohorts of (study and control groups). The study group will undergo AspireAssist gastrostomy tube placement and the control group will undergo standard decompressive percutaneous gastrostomy tube placement. Individuals who present for venting gastrostomy placement in clinic or as consults will be approached for inclusion. Gastrostomy tubes will be placed 1-2 days after enrollment to allow for thoroughly consideration of inclusion by potential participants. Gastrostomy tube placement will be completed endoscopically in the standard "pull" method in both the AspireAssist and PEG groups. Questionnaires will be completed at 7 and 30 days.
The primary objective of this study is to evaluate to compare healthcare utilization, including major and minor tube related complications between the two groups. Secondary objectives of this study are to compare changes in the ability to eat and drink after placement of the gastrostomy tube and to evaluate changes in quality of life before and after gastrostomy tube placement.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Malignant (cancer of any type) gastric or small bowel obstruction referred to surgery for placement of a venting gastrostomy tube for gastric decompression
Able to demonstrate the ability to use the AspireAssist prior to placement
You may not be if
Those who are immobile and unable to at least sit up in bed to vent the gastrostomy tube.
Undergoing placement of a gastrostomy tube for any other indication other than malignant small bowel or gastric outlet obstruction.
Absolute contraindications to gastrostomy tube placement, such as occluding oral or esophageal tumors
Clareo Health | AspireAssist for Palliative Venting Gastrostomy in Malignant Bowel Obstruction Patients